Meeting the challenge of the 2019 novel coronavirus disease in patients with cancer.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 32324273.
- Also identified by DOI 10.1002/cncr.32919 and PMC identifier 7264676.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The alarming situation of the 2019 novel coronavirus disease (COVID‐19) is contrasted by the limited efforts to curb the spread and impact of the disease among patients with cancer. This commentary proposes a simple 5‐part strategy plus rapidly expanded use of telemedicine to anticipate and deal with COVID‐19 and, by extension, future epidemics in patients with cancer.
Medical subject headings
- Betacoronavirus
- Coronavirus Infections
- Neoplasms
- Pandemics
- Pneumonia, Viral
- Telemedicine